Supply and Delivery of Human Seasonal Trivalent Influenza Vaccines

nes can include Cell Based, Egg Based or Recombinant Vaccines. The HSE reserves the right to award a portion of the total tendered dose amount to cohort specific vaccines. The HSE will confirm its requirements after evaluation, at Contract stage. Tenderers should include provision for an additional

200,000 doses or 16 percent of the potential awarded quantity as a contingency stock.